Without fanfare, the U.S. Centers for Disease Control and Prevention, August 11, 2022, reversed all its COVID-19 guidelines. In fact, many have noted it appears the CDC wanted to bring as little attention to it as possible.1 This is understandable, considering the new guidelines more or less admit the original rules were in error, without… Read More »
India is one of the world’s biggest manufacturers of drugs and vaccines, but that hasn’t made it immune to COVID-19 supply instability. Now, the government is locking up at least one treatment for itself. As COVID-19 cases mount—and demand for treatments spikes—India has banned exports of Gilead Sciences’ pandemic antiviral remdesivir, Bloomberg reports, citing a statement… Read More »
Health Tech Feb 28, 2020• By JESSICA DaMASSA, WTF HEALTH Savvy health tech startups can learn how the differing investment priorities of venture capital funds and strategic investors (those tied to large healthcare organizations like health plans, pharma companies, and health systems) can impact everything from their capital raise to their ability to gain new… Read More »